Rupesh Agrawal Selected Research

Posterior Uveitis

1/2022	MULTICOLOR CONFOCAL SCANNING LASER OPHTHALMOSCOPE IMAGING IN POSTERIOR UVEITIS.
6/2018	Morphometric features on enhanced depth imaging optical coherence tomography scans in idiopathic posterior uveitis or panuveitis.
7/2017	Viral posterior uveitis.
1/2017	Re: Jaffe et al.: Injectable fluocinolone acetonide long-acting implant for noninfectious intermediate uveitis, posterior uveitis, and panuveitis: two-year results (Ophthalmology. 2016;123:1940-1948).
1/2016	Management of noninfectious posterior uveitis with intravitreal drug therapy.
12/2014	Immunopharmacotherapy of non-infectious uveitis: where do we stand?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rupesh Agrawal Research Topics

Disease

18	Inflammation (Inflammations) 07/2022 - 01/2012
16	Uveitis 01/2022 - 04/2009
11	Ocular Tuberculosis 06/2022 - 01/2015
9	Panuveitis 10/2022 - 12/2014
8	COVID-19 04/2022 - 01/2021
8	Wounds and Injuries (Trauma) 04/2022 - 08/2013
8	Endophthalmitis (Ophthalmia) 01/2022 - 08/2013
8	Cataract (Cataracts) 08/2021 - 01/2012
8	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 11/2016
7	Macular Degeneration (Age-Related Maculopathy) 09/2022 - 01/2015
7	Choroiditis 03/2022 - 12/2016
6	Anterior Uveitis 07/2022 - 03/2015
6	Posterior Uveitis 01/2022 - 12/2014
6	Choroidal Neovascularization 10/2021 - 09/2016
6	Infections 01/2021 - 08/2013
6	HIV Infections (HIV Infection) 10/2020 - 12/2013
5	Retinitis 01/2022 - 01/2016
5	Scleritis (Episcleritis) 01/2021 - 01/2016
4	Intermediate Uveitis (Chronic Cyclitis) 01/2021 - 01/2017
4	Macular Edema 06/2018 - 02/2016
4	Dry Eye Syndromes (Dry Eye Syndrome) 10/2017 - 12/2016
4	Cytomegalovirus Retinitis 12/2016 - 11/2013
3	Atrophy 04/2021 - 01/2018
3	Retinal Vasculitis 01/2021 - 01/2017
3	Glaucoma 01/2021 - 01/2017
3	Opportunistic Infections (Opportunistic Infection) 10/2020 - 12/2016
3	Ischemia 06/2017 - 02/2016
2	Neoplasms (Cancer) 09/2022 - 01/2015
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 10/2020
2	Epiretinal Membrane (Epiretinal Membranes) 01/2022 - 12/2018
2	Ganglion Cysts (Ganglion) 01/2022 - 01/2021
2	Vision Disorders (Hemeralopia) 10/2021 - 01/2015
2	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 08/2021 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 10/2020 - 04/2017
2	Polypoidal Choroidal Vasculopathy 01/2019 - 08/2018
2	Birdshot Chorioretinopathy 01/2019 - 03/2017
2	Vasculitis (Vasculitides) 12/2017 - 12/2016
2	Tuberculosis (Tuberculoses) 01/2017 - 09/2016
2	Hyphema 05/2016 - 10/2013
2	Optic Nerve Diseases (Optic Neuropathy) 02/2015 - 08/2013
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 02/2022
1	Bronchopulmonary Dysplasia 02/2022
1	Hemorrhage 01/2022
1	Rupture 02/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Dementia (Dementias) 01/2021
1	Myopia 01/2021
1	Retinal Detachment (Retinal Detachments) 01/2021
1	Tuberculoma 01/2021
1	Granuloma 01/2021
1	Pain (Aches) 01/2021
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 12/2020
1	Conjunctivitis 11/2020

Drug/Important Bio-Agent (IBA)

29	Retinaldehyde (Retinal)IBA 10/2022 - 10/2013
13	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2015
10	CytokinesIBA 01/2019 - 11/2013
9	Biomarkers (Surrogate Marker)IBA 04/2022 - 12/2013
8	SteroidsIBA 01/2022 - 08/2013
7	Fluorescein (Funduscein)FDA LinkGeneric 01/2021 - 02/2016
5	2-toluenesulfonamide (OTS)IBA 04/2022 - 09/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022 - 09/2016
4	Ganciclovir (Cytovene)FDA LinkGeneric 07/2022 - 04/2015
4	Biological ProductsIBA 01/2022 - 01/2014
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 08/2013
4	Pharmaceutical PreparationsIBA 12/2020 - 02/2015
3	VaccinesIBA 02/2022 - 08/2021
3	Endothelial Growth FactorsIBA 10/2021 - 09/2016
3	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2015
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021 - 12/2016
3	afliberceptIBA 10/2020 - 01/2015
3	Ranibizumab (Lucentis)FDA Link 01/2018 - 01/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2022 - 01/2018
2	Methylprednisolone FDA LinkGeneric 01/2022 - 08/2013
2	Moxifloxacin (Avelox)FDA Link 08/2021 - 10/2016
2	Bevacizumab (Avastin)FDA Link 01/2018 - 01/2015
2	GoldIBA 12/2017 - 01/2017
2	Immunologic Factors (Immunomodulators)IBA 09/2016 - 01/2016
1	Sunitinib (Sutent)FDA Link 09/2022
1	Valganciclovir FDA Link 07/2022
1	COVID-19 VaccinesIBA 02/2022
1	mRNA VaccinesIBA 08/2021
1	BNT162 VaccineIBA 08/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2020

Therapy/Procedure

36	Therapeutics 07/2022 - 04/2009
6	Lasers (Laser) 01/2022 - 01/2016
5	Intravitreal Injections 02/2021 - 04/2015
4	Vitrectomy 01/2022 - 08/2013
4	Injections 10/2021 - 01/2017
3	Highly Active Antiretroviral Therapy (HAART) 04/2017 - 12/2014
2	Drug Therapy (Chemotherapy) 09/2022 - 01/2016
2	Conservative Treatment 01/2020 - 08/2013
2	Intraocular Lenses (Intraocular Lens) 05/2016 - 01/2012
1	Artificial Respiration (Mechanical Ventilation) 02/2022
1	Hysterectomy 01/2022
1	Biological Therapy 01/2022
1	Immunomodulation 01/2021